DMD Digital Health Connections Group Inc (APTOF) Stock
APTOF is no longer traded. DMD Digital Health Connections Group was delisted from the Nasdaq in July 2026.
Prices on this page are historical; the last trade was July 2, 2026 at $1.69.
DMD Digital Health Connections Group stock price history
APTOF final trading statistics
- Final close
- $1.69
- Final trading day
- Jul 2, 2026
- Market cap at delisting
- $4.31M
- Shares outstanding
- 2.55M
- Final 52-week range
- $0.86 – $1.85
- Avg. volume (final 3 mo.)
- 2,143
- All-time high (split-adj.)
- $850505.44 · Mar 2000
- All-time low (split-adj.)
- $0.80 · Jun 2025
- Return since IPO
- -97.9%
- Beta
- 0.34
- Book value / share
- -$13.58
- Price / book
- -0.12
DMD Digital Health Connections Group annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | -$25.5M | — |
| FY2024 | $0.00 | -$25.4M | -$269.20 |
| FY2023 | $0.00 | -$51.2M | — |
| FY2022 | $0.00 | -$41.8M | -$153.45 |
| FY2021 | $0.00 | -$65.4M | -$207.27 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes. It has license agreements with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
DMD Digital Health Connections Group stock FAQ
What happened to DMD Digital Health Connections Group stock?
DMD Digital Health Connections Group stock was delisted from the Nasdaq. Its final close was $1.69 on July 2, 2026.
Is APTOF stock still trading?
No. APTOF was delisted from the Nasdaq in July 2026 and no longer trades on a U.S. exchange.
What was the last price of APTOF stock?
APTOF closed at $1.69 on its final trading day, July 2, 2026, for a market value of about $4.31M.
What were DMD Digital Health Connections Group's revenue and earnings in its last full fiscal year?
DMD Digital Health Connections Group reported revenue of $0.00 and net income of -$25.5M in fiscal 2025, its last full year as a public company.
When did DMD Digital Health Connections Group go public?
DMD Digital Health Connections Group Inc stock began trading on October 23, 2014.